Guselkumab in moderately to severely active ulcerative colitis: Another interleukin-23p19 subunit inhibitor or more?

Saved in:
Bibliographic Details
Title: Guselkumab in moderately to severely active ulcerative colitis: Another interleukin-23p19 subunit inhibitor or more?
Authors: Orlando A; IBD Unit, Villa Sofia-Cervello Hospital, 90146 Palermo, Italy. Electronic address: ambrogiorlando@gmail.com., Macaluso FS; IBD Unit, Villa Sofia-Cervello Hospital, 90146 Palermo, Italy.
Source: Med (New York, N.Y.) [Med] 2025 Mar 14; Vol. 6 (3), pp. 100605.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-6340
DOI:10.1016/j.medj.2025.100605